3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow cendakimab: new trials by email Literature Review of cendakimab trials Research Report on cendakimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis CC-93538 - Eosinophilic Esophagitis | Phase 3 | Completed | Celgene | 367 | 2022-08-09 | 2026-04-06 |
| A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis CC-93538, Placebo - Eosinophilic Gastroenteritis | Phase 3 | Completed | Celgene | 48 | 2022-03-04 | 2026-09-14 |
| A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis CC-93538, Placebo - Eosinophilic Esophagitis | Phase 3 | Completed | Celgene | 430 | 2021-02-22 | 2025-03-13 |
Gastroenteritis (3) · Gastrointestinal Diseases (3) · Eosinophilia (2) · Eosinophilic Esophagitis (2) · Esophageal Diseases (2) · Esophagitis (2) · Hypersensitivity (2) · Digestive System Diseases (1) · Eosinophilic enteropathy (1)
Celgene (3)
Japan (3) · Argentina (2) · Australia (2) · Austria (2) · Belgium (2) · Canada (2) · Germany (2) · Israel (2) · Italy (2) · Poland (2) · Portugal (2) · Spain (2) · Switzerland (2) · United Kingdom (2) · United States (2)